机构:[1]Allergy and Cancer Center Otorhinolaryngology Hospital, the First Affiliated Hospital of Sun Yat-sen University, and Otorhinolaryngology Institute of Sun Yat-sen University, Guangzhou, China,中山大学附属第一医院[2]Department of Otolaryngology, Chinese PLA General Hospital, Beijing, China,[3]Department of Otolaryngology, Yuebei People’s Hospital, Shaoguan, China,[4]Department of Otolaryngology, the First Affiliated Hospital of Nanchang University, Nanchang, China[5]Department of Otolaryngology, Beijing Tongren Hospital, Capital Medical University, Beijing, China临床科室耳鼻咽喉-头颈外科首都医科大学附属北京同仁医院首都医科大学附属同仁医院
Background: Although Interleukin (IL)-17A has been suggested to play a role in corticosteroid hyporesponsiveness, whether IL-17A is able to affect the sensitivity of MUC5AC to intranasal corticosteroid treatment in patients with allergic rhinitis (AR) is unclear. Methods: Twenty patients with moderate to severe AR were enrolled in this study and the expression of MUC5AC, IL-17A, and glucocorticoid receptor beta (GR beta) was detected using immunochemical staining and quantitative reverse transcription polymerase chain reaction (RT-PCR) before and after treatment with fluticasone propionate (FP) nasal spray for 4 weeks, respectively. In addition, the effects of FP on IL-13- and IL-17A-induced MUC5AC and GR beta were also evaluated in the primarily cultured human nasal epithelial cells (HNECs) in vitro. Results: The increased MUC5AC expression was associated with IL-17A levels in AR, and IL-17A was found to affect the inhibition of MUC5AC by corticosteroid treatment. Both IL-13 and IL-17A significantly promoted MUC5AC mRNA expression in HNECs, and FP treatment was able to significantly inhibit MUC5AC mRNA expression in HNECs induced by IL-13 but not for that induced by IL-17A. Also, IL-17A but not IL-13 promoted GR beta mRNA expression in HNECs, which was not affected by administration of corticosteroid. Conclusion: Our results suggest that the sensitivity of MUC5AC to topical corticosteroid is negatively associated with IL-17A in AR patients. This might help us to gain more insight into the pathophysiology and the pharmacotherapeutic mechanisms on AR treatment. (Am J Rhinol Allergy 26, 359-364, 2012; doi: 10.2500/ajra.2012.26.3795)
基金:
National Natural Science Fund of ChinaNational Natural Science Foundation of China [U0832007, 81070771, 81070772]; Guangdong Province Natural Science [S2011010004634, S2011020002295]; Ministry of Hygiene [201202005]; Program for New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-10-0851]
第一作者机构:[1]Allergy and Cancer Center Otorhinolaryngology Hospital, the First Affiliated Hospital of Sun Yat-sen University, and Otorhinolaryngology Institute of Sun Yat-sen University, Guangzhou, China,
共同第一作者:
通讯作者:
通讯机构:[1]Allergy and Cancer Center Otorhinolaryngology Hospital, the First Affiliated Hospital of Sun Yat-sen University, and Otorhinolaryngology Institute of Sun Yat-sen University, Guangzhou, China,[5]Department of Otolaryngology, Beijing Tongren Hospital, Capital Medical University, Beijing, China[*1]Allergy and Cancer Center, Otorhinolaryngology Hospital, the First Affiliated Hospital of Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Guangzhou, China 510080[*2]Department of Otolaryngology, Beijing Tongren Hospital, Capital Medical University, No. 1, Dongjiaomin Lane, Beijing, China100005
推荐引用方式(GB/T 7714):
Tang Haocheng,Wang Hongtian,Bai Jing,et al.Sensitivity of MUC5AC to topical corticosteroid is negatively associated with interleukin-17A in patients with allergic rhinitis[J].AMERICAN JOURNAL OF RHINOLOGY & ALLERGY.2012,26(5):359-364.doi:10.2500/ajra.2012.26.3795.
APA:
Tang, Haocheng,Wang, Hongtian,Bai, Jing,Ding, Minghong,Liu, Wenlong...&Fang, Jugao.(2012).Sensitivity of MUC5AC to topical corticosteroid is negatively associated with interleukin-17A in patients with allergic rhinitis.AMERICAN JOURNAL OF RHINOLOGY & ALLERGY,26,(5)
MLA:
Tang, Haocheng,et al."Sensitivity of MUC5AC to topical corticosteroid is negatively associated with interleukin-17A in patients with allergic rhinitis".AMERICAN JOURNAL OF RHINOLOGY & ALLERGY 26..5(2012):359-364